Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UVADEX in Immune-related Colitis
NCT06646016Phase 2Withdrawn
- Sponsor
- Therakos
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methoxsalen in immune-related colitis (IRC), sponsored by Therakos. Planned start Dec 2025; status: withdrawn.
02
Drugs
methoxsalen
03
Conditions
immune-related colitis (IRC)
Beyond the preview
Go deeper on NCT06646016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06646016.